FI821253L - Galenisk produkt - Google Patents

Galenisk produkt

Info

Publication number
FI821253L
FI821253L FI821253A FI821253A FI821253L FI 821253 L FI821253 L FI 821253L FI 821253 A FI821253 A FI 821253A FI 821253 A FI821253 A FI 821253A FI 821253 L FI821253 L FI 821253L
Authority
FI
Finland
Prior art keywords
active compound
calcium
galenisk
product
antagonistic
Prior art date
Application number
FI821253A
Other languages
English (en)
Finnish (fi)
Other versions
FI821253A7 (fi
FI821253A0 (fi
Inventor
Heinz Einig
Volker Buehler
Winfried Koch
Joachim Arthur Schwarz
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6129505&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI821253(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Basf Ag filed Critical Basf Ag
Publication of FI821253A0 publication Critical patent/FI821253A0/fi
Publication of FI821253A7 publication Critical patent/FI821253A7/fi
Publication of FI821253L publication Critical patent/FI821253L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
FI821253A 1981-04-07 1982-04-07 Galenisk produkt FI821253L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813113901 DE3113901A1 (de) 1981-04-07 1981-04-07 Wirkstoffzubereitung zur oralen applikation

Publications (3)

Publication Number Publication Date
FI821253A0 FI821253A0 (fi) 1982-04-07
FI821253A7 FI821253A7 (fi) 1982-10-08
FI821253L true FI821253L (fi) 1982-10-08

Family

ID=6129505

Family Applications (1)

Application Number Title Priority Date Filing Date
FI821253A FI821253L (fi) 1981-04-07 1982-04-07 Galenisk produkt

Country Status (17)

Country Link
EP (1) EP0063266B1 (enrdf_load_stackoverflow)
JP (1) JPS57175113A (enrdf_load_stackoverflow)
AT (1) ATE14076T1 (enrdf_load_stackoverflow)
AU (1) AU555093B2 (enrdf_load_stackoverflow)
CA (1) CA1184497A (enrdf_load_stackoverflow)
DE (2) DE3113901A1 (enrdf_load_stackoverflow)
DK (1) DK157482A (enrdf_load_stackoverflow)
ES (1) ES511208A0 (enrdf_load_stackoverflow)
FI (1) FI821253L (enrdf_load_stackoverflow)
GR (1) GR74770B (enrdf_load_stackoverflow)
HU (1) HU186855B (enrdf_load_stackoverflow)
IE (1) IE52985B1 (enrdf_load_stackoverflow)
IL (1) IL65328A (enrdf_load_stackoverflow)
NO (1) NO157204C (enrdf_load_stackoverflow)
NZ (1) NZ200244A (enrdf_load_stackoverflow)
PT (1) PT74705B (enrdf_load_stackoverflow)
ZA (1) ZA822327B (enrdf_load_stackoverflow)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
LU86077A1 (fr) * 1985-09-18 1987-04-02 Pharlyse Sa Nouvelles formes galeniques du verapamil,leur fabrication et medicaments contenant ces nouvelles formes galeniques
LU86099A1 (fr) * 1985-09-30 1987-04-02 Pharlyse Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant
IE58401B1 (en) * 1986-06-20 1993-09-08 Elan Corp Plc Controlled absorption pharmaceutical composition
US4981871A (en) * 1987-05-15 1991-01-01 Abelson Mark B Treatment of ocular hypertension with class I calcium channel blocking agents
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
DE3809764A1 (de) * 1988-03-23 1989-10-05 Knoll Ag Mischung aus alginaten und polyacrylaten und deren verwendung
US5230901A (en) * 1988-03-23 1993-07-27 Knoll Ag Sustained release tablet of a mixture of alginates and polyacrylates
ES2045281T3 (es) * 1988-07-13 1994-01-16 Knoll Ag Forma de medicamento de accion retardada sobre la base de alginatos.
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
DE3932378A1 (de) * 1989-09-28 1991-04-11 Knoll Ag Feste arzneiform mit hohem verapamil-gehalt
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US6083532A (en) 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154810B (de) * 1961-04-01 1963-09-26 Knoll Ag Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
DE1467781A1 (de) * 1963-07-15 1968-12-05 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Dragees mit verlaengerter Wirkstofffreigabe

Also Published As

Publication number Publication date
DK157482A (da) 1982-10-08
IL65328A0 (en) 1982-05-31
HU186855B (en) 1985-10-28
DE3113901A1 (de) 1982-10-28
JPS57175113A (en) 1982-10-28
PT74705A (en) 1982-05-01
EP0063266A3 (en) 1983-05-04
ATE14076T1 (de) 1985-07-15
EP0063266A2 (de) 1982-10-27
DE3264519D1 (en) 1985-08-08
IL65328A (en) 1985-06-30
ES8307496A1 (es) 1983-08-16
IE820812L (en) 1982-10-07
AU555093B2 (en) 1986-09-11
NO157204B (no) 1987-11-02
FI821253A7 (fi) 1982-10-08
NO157204C (no) 1988-02-10
ZA822327B (en) 1983-03-30
AU8238482A (en) 1982-10-14
GR74770B (enrdf_load_stackoverflow) 1984-07-12
IE52985B1 (en) 1988-04-27
CA1184497A (en) 1985-03-26
PT74705B (en) 1983-11-14
ES511208A0 (es) 1983-08-16
NZ200244A (en) 1984-08-24
NO821084L (no) 1982-10-08
EP0063266B1 (de) 1985-07-03
FI821253A0 (fi) 1982-04-07

Similar Documents

Publication Publication Date Title
FI821253A0 (fi) Galenisk produkt
NO171365C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
ATE163849T1 (de) Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
FR2422620A1 (fr) Derives du stilbene, leur preparation et leur application en tant que medicaments
FR2694004B1 (fr) Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
ATE194987T1 (de) Substituierte dibenzoxazepinverbindungen, pharmazeutische zusammensetzungen und anwendungsmethoden
DE60022895D1 (de) Pdgf-rezeptor-kinase hemmende verbindungen, deren herstellung, reinigung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
SE8404065D0 (sv) Novel biologically active compounds
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
KR890004705A (ko) 항바이러스성 제제
ES475533A1 (es) Un metodo para la preparacion de formas racemicas y optica- mente activas de 2-(4-difenilil)-n-(dimetilamino-alquil)pro-pionamida
FR2361110A1 (fr) Medicaments anthelminthiques renfermant une association synergique de substances actives
ATE85218T1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
ES2171749T3 (es) Composiciones farmaceuticas que contienen inhibidores de la agregacion de plaquetas.
IL87867A (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-3-phenyl-azo-pyridine derivative
KR890007737A (ko) 진토작용을 하는 약제
MX9302929A (es) Derivados de tetrahidro y perhidroisoquinolina y medios terapeuticos que los contienen.
ATE15041T1 (de) Verbindung mit schmerzlinderungs-, entzuendungshemmungs- und antipyrexiewirkung, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
TH3319A (th) กรรมวิธีสำหรับการเตรียม n-(2-พิริติล)-2-เมทธิล-4-ไฮดรอกซี-2h-1,2-เบนโซไทอะซิน-3-คาร์บอกซะไมด์-1,1ไดออกไซด์
FR2567755B1 (fr) Nouveau medicament anti-tumoral contenant comme ingredient actif le triacetoxy-1,8,9 anthracene
KR890002058A (ko) 간질 및 불안 상태의 예방 및 치료용 2,4,6-트리스-3-급-부틸아미노-1,-3,-5-트리아진

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: BASF AKTIENGESELLSCHAFT